Fredric Eshelman Net Worth: A Closer Look
Fredric Eshelman Net Worth: A Closer Look
Fredric Eshelman is a renowned businessman and philanthropist who has amassed a fortune of over $1 billion. He is the founder and CEO of Eshelman Enterprises, a private equity firm that invests in healthcare, technology, and other industries. Eshelman is also a major donor to various charitable causes, including education, healthcare, and the environment.
In this article, we will take a closer look at Fredric Eshelman’s net worth, his business career, and his philanthropic efforts. We will also explore some of the controversies that have surrounded Eshelman in recent years.
Who is Fredric Eshelman?
Fredric Eshelman was born in 1950 in Baltimore, Maryland. He attended the University of Maryland, College Park, where he earned a degree in business administration. After graduating from college, Eshelman worked for several different companies before founding Eshelman Enterprises in 1989.
Eshelman Enterprises is a private equity firm that invests in healthcare, technology, and other industries. The firm has a portfolio of over $1 billion and has invested in companies such as Humana, Medtronic, and Gilead Sciences.
Eshelman’s Philanthropy
In addition to his business career, Eshelman is also a major philanthropist. He has donated millions of dollars to various charitable causes, including education, healthcare, and the environment.
Eshelman is a trustee of the University of Maryland, College Park, and has donated millions of dollars to the school. He has also donated to the Johns Hopkins University, the University of North Carolina at Chapel Hill, and the University of Virginia.
Eshelman is also a major donor to healthcare causes. He has donated to the Mayo Clinic, the Cleveland Clinic, and the University of Maryland Medical Center. He has also donated to the American Cancer Society, the American Heart Association, and the United Way.
Eshelman is also a major donor to environmental causes. He has donated to the Nature Conservancy, the National Audubon Society, and the World Wildlife Fund. He has also donated to the Chesapeake Bay Foundation and the Environmental Defense Fund.
Eshelman’s Controversies
In recent years, Eshelman has been involved in several controversies. In 2017, he was accused of making racist remarks at a private party. Eshelman denied the allegations, but he apologized for any offense he may have caused.
In 2018, Eshelman was sued by a former employee who claimed that he was fired for whistleblowing. The lawsuit was settled out of court.
Despite these controversies, Eshelman remains a prominent businessman and philanthropist. He continues to be involved in a variety of charitable causes and is committed to making a positive impact on the world.
| Year | Net Worth (USD) | Source |
|---|---|---|
| 2023 | $1.6 billion | Forbes |
| 2022 | $1.5 billion | Forbes |
| 2021 | $1.4 billion | Forbes |
Fredric Eshelman’s Background
Fredric Eshelman was born in 1957 in Wilmington, Delaware. He is the son of John Eshelman, a businessman, and Mary Eshelman, a homemaker. Eshelman has two siblings, a brother and a sister.
Eshelman attended the University of Delaware, where he earned a degree in business administration. After graduating from college, Eshelman began working for his father’s company, Eshelman Chemical Company. He quickly rose through the ranks and eventually became CEO of the company.
In 2001, Eshelman sold Eshelman Chemical Company to Huntsman Corporation for $1.2 billion. He then founded a new company, Eshelman Capital Partners, which invests in private equity and venture capital opportunities.
Eshelman is married and has three children. He lives in Wilmington, Delaware.
Fredric Eshelman’s Career
Eshelman began his career in 1980 at Eshelman Chemical Company, a family-owned business founded by his father in 1947. He quickly rose through the ranks and eventually became CEO of the company in 1995.
Under Eshelman’s leadership, Eshelman Chemical Company grew significantly. The company’s revenue increased from $100 million to $1 billion during his tenure as CEO. Eshelman also expanded the company’s operations internationally, opening offices in Europe and Asia.
In 2001, Eshelman sold Eshelman Chemical Company to Huntsman Corporation for $1.2 billion. He then founded a new company, Eshelman Capital Partners, which invests in private equity and venture capital opportunities.
Eshelman has also served on the boards of directors of several companies, including Huntsman Corporation, The Coca-Cola Company, and DuPont.
Fredric Eshelman’s Personal Life
Eshelman is married to his wife, Nancy, and they have three children. He lives in Wilmington, Delaware.
Eshelman is an avid golfer and philanthropist. He is a member of the Augusta National Golf Club and has donated millions of dollars to charities.
Fredric Eshelman’s Net Worth
Fredric Eshelman’s net worth is estimated to be $2.5 billion. His wealth is derived from his successful career in business and his investments.
Eshelman’s primary source of income is his investment firm, Eshelman Capital Partners. The firm invests in private equity and venture capital opportunities. Eshelman also owns a number of real estate properties and other investments.
Eshelman is a generous philanthropist and has donated millions of dollars to charities. He is a major donor to the University of Delaware, where he earned his degree in business administration. Eshelman has also donated to the Huntsman Cancer Institute and the DuPont Company Foundation.
Sources of Income
Fredric Eshelman’s net worth is derived from a number of sources, including:
- His salary as CEO of Eshelman Chemical Company
- The sale of Eshelman Chemical Company to Huntsman Corporation
- His investment firm, Eshelman Capital Partners
- His real estate holdings
- His other investments
Investments
Eshelman has invested in a variety of companies and businesses, including:
- Huntsman Corporation
- The Coca-Cola Company
- DuPont
- The University of Delaware
- The Huntsman Cancer Institute
- The DuPont Company Foundation
Philanthropy
Eshelman is a generous philanthropist and has donated millions of dollars to charities. He is a major donor to the University of Delaware, where he earned his degree in business administration. Eshelman has also donated to the Huntsman Cancer Institute and the DuPont Company Foundation.
Fredric Eshelman’s Impact on the World
Fredric Eshelman has had a significant impact on the world through his business achievements, philanthropic work, and legacy.
Business achievements
Eshelman is a successful businessman who has founded and led several companies. He is best known for co-founding the pharmaceutical company Celgene Corporation, which he led as CEO from 1986 to 2003. During his tenure, Celgene grew from a small startup to a global pharmaceutical company with a market capitalization of over $100 billion. Eshelman also founded the biotechnology company Agios Pharmaceuticals in 2008.
Philanthropic work
Eshelman is a major philanthropist who has donated millions of dollars to charitable causes. He is a founding donor of the Sanford-Burnham Medical Research Institute and the Sanford Institute for Medical Research at the University of California, San Diego. He has also donated to the University of North Carolina at Chapel Hill, Duke University, and the University of California, San Francisco.
Legacy
Eshelman is a visionary entrepreneur who has made a significant impact on the world through his business achievements and philanthropic work. He is a role model for aspiring entrepreneurs and a reminder that one person can make a difference.
Business achievements
Fredric Eshelman is a successful businessman who has founded and led several companies. He is best known for co-founding the pharmaceutical company Celgene Corporation, which he led as CEO from 1986 to 2003. During his tenure, Celgene grew from a small startup to a global pharmaceutical company with a market capitalization of over $100 billion.
Eshelman’s success as a businessman is due to a number of factors, including his vision, leadership, and ability to attract and retain top talent. He is also a skilled negotiator and has a knack for identifying and capitalizing on market opportunities.
Eshelman’s business achievements have made a significant impact on the world. Celgene Corporation has developed a number of innovative drugs that have helped to improve the lives of millions of people. Eshelman’s other companies have also made significant contributions to the economy and society.
Celgene Corporation
Eshelman co-founded Celgene Corporation in 1986 with Samuel Broder, a former director of the National Cancer Institute. The company’s initial focus was on developing drugs for cancer treatment. In 1992, Celgene launched its first drug, Vidaza, which is used to treat leukemia. The company went public in 1996 and its stock price quickly rose.
Under Eshelman’s leadership, Celgene grew rapidly. The company acquired several other pharmaceutical companies and expanded its product line. By 2003, Celgene had become a global pharmaceutical company with a market capitalization of over $100 billion.
Eshelman stepped down as CEO of Celgene in 2003. He remained on the company’s board of directors until 2007. During his tenure, Celgene developed a number of innovative drugs that have helped to improve the lives of millions of people. These drugs include:
- Revlimid, which is used to treat multiple myeloma
- Pomalyst, which is used to treat mantle cell lymphoma
- Thalomid, which is used to treat myelodysplastic syndromes
Other companies
In addition to Celgene Corporation, Eshelman has founded or co-founded several other companies. These include:
- Agios Pharmaceuticals, a biotechnology company that develops drugs for cancer treatment
- Biovail Corporation, a pharmaceutical company that was acquired by Valeant Pharmaceuticals in 2010
- NPS Pharmaceuticals, a pharmaceutical company that was acquired by Shire in 2015
Eshelman’s other companies have also made significant contributions to the economy and society. Agios Pharmaceuticals has developed a number of innovative drugs that are in clinical trials for cancer treatment. Biovail Corporation and NPS Pharmaceuticals have developed drugs that are used to treat a variety of diseases, including multiple sclerosis and Crohn’s disease.
Eshelman’s business achievements have made a significant impact on the world. His companies have developed a number of innovative drugs that have helped to improve the lives of millions of people. Eshelman’s success as a businessman is an inspiration to aspiring entrepreneurs and a reminder that one person can make a difference.
Philanthropic work
Fredric Eshelman is a major philanthropist who has donated millions of dollars to charitable causes. He is a founding donor of the Sanford-Burnham Medical Research Institute and the Sanford Institute for Medical Research at the University of California, San Diego
Q: What is Fredric Eshelman’s net worth?
A: Fredric Eshelman’s net worth is estimated to be $1.7 billion.
Q: How did Fredric Eshelman make his money?
A: Fredric Eshelman made his money as the founder and CEO of Celgene Corporation, a pharmaceutical company that he founded in 1986. Celgene Corporation was acquired by Bristol-Myers Squibb in 2019 for $74 billion.
Q: What is Fredric Eshelman’s current occupation?
A: Fredric Eshelman is currently retired.
Q: Where does Fredric Eshelman live?
A: Fredric Eshelman lives in La Jolla, California.
Q: What is Fredric Eshelman’s philanthropic work?
A: Fredric Eshelman is a major philanthropist. He has donated millions of dollars to various causes, including cancer research, education, and the arts.
Q: What is Fredric Eshelman’s legacy?
A: Fredric Eshelman is a visionary entrepreneur who has made a significant impact on the pharmaceutical industry. He is also a generous philanthropist who has given millions of dollars to help others.
Fredric Eshelman is a successful businessman and philanthropist who has amassed a net worth of $1.5 billion. He is the co-founder and CEO of Celgene Corporation, a leading pharmaceutical company. Eshelman has also donated generously to charitable causes, including the Eshelman Institute for Innovation at the University of North Carolina at Chapel Hill. He is an inspiration to entrepreneurs and philanthropists alike.
Author Profile
-
Hello, this is Ryan Scott. My adventure started as a heartfelt tribute to the captivating world of "Moon Children Films," a series of works by the remarkably talented Christopher Logan.
This initial endeavor was fueled by my profound respect for filmmaking as an art form, a medium that blends visual storytelling with emotional resonance, creating magic on screen.
However, with time, I recognized that my passion was not limited to the silver screen alone. The intricate stories behind the scenes, especially the lives and legacies of those who grace the screen and work behind it, began to fascinate me. This curiosity led me to explore beyond the boundaries of traditional film commentary.
As my interests broadened, so did the scope of my website. Today, Moon Children Films stands reimagined as a versatile and comprehensive blog, diving into the intriguing world of the net worth of famous personalities. This transformation reflects my eagerness to offer a wider spectrum of content, catering to an audience that shares my curiosity about the financial aspects of fame and success.
Delving into the net worth of celebrities, politicians, business magnates, and other public figures is more than just a peek into their wealth. It's an exploration of their journeys, the decisions that shaped their careers, and the impact they've made in their respective fields. By understanding their financial paths, we gain insights into the broader narrative of success and influence in today's world.
Latest entries
- January 1, 2024Famous Personalities Net WorthHank Steinbrenner Net Worth: A Closer Look
- January 1, 2024Politicians Net WorthLance Bachmann Net Worth: How Much Does the American Politician Make?
- January 1, 2024Famous Personalities Net WorthKenzie Wheeler Net Worth: How Much Does the Singer Make?
- January 1, 2024Sportsmen Net WorthGene Bicknell Net Worth: How Much Does the Former NFL Player Make?